Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Expert Opinion on Drug Safety

• Publication date

  2012-08-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/14740338.2012.705827PMID 22788832
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of healthy lifestyle on mortality in people with normal blood pressure, LDL cholesterol, and C-reactive protein

  2013cited by this paper
• A tea catechin, epigallocatechin-3-gallate, is a unique modulator of the farnesoid X receptor.

  2012cited by this paper
• Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases

  2012cited by this paper
• Application of polyunsaturated fatty acids in internal medicine: beyond the established cardiovascular effects

  2012cited by this paper
• ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

  2011cited by this paper
• Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study

  2011cited by this paper
• The Role of Red Yeast Rice for the Physician

  2011cited by this paper
• Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes.

  2011cited by this paper
• ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

  2011cited by this paper
• Chinese herbal medicines for hypercholesterolemia.

  2011cited by this paper
• Differential effects on inhibition of cholesterol absorption by plant stanol and plant sterol esters in apoE−/− mice

  2011cited by this paper
• Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis.

  2011cited by this paper
• Primary hyperlipidemias in children: effect of plant sterol supplementation on plasma lipids and markers of cholesterol synthesis and absorption

  2011cited by this paper
• Clinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet

  2011cited by this paper
• Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials.

  2011cited by this paper
• Influence of consumption of probiotics on the plasma lipid profile: a meta-analysis of randomised controlled trials.

  2011cited by this paper
• Nutritional antioxidants and adaptive cell responses: an update.

  2011cited by this paper
• Culinary plants and their potential impact on metabolic overload

  2011cited by this paper
• Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals.

  2010cited by this paper
• The effect of a very high daily plant stanol ester intake on serum lipids, carotenoids, and fat-soluble vitamins.

  2010cited by this paper
• Policosanols as Nutraceuticals: Fact or Fiction

  2010cited by this paper
• Cardiovascular and metabolic effects of Berberine.

  2010cited by this paper
• Role of dietary supplements in lowering low-density lipoprotein cholesterol: a review.

  2010cited by this paper
• Association between the serum folate levels and tea consumption during pregnancy.

  2010cited by this paper
• Economic Evaluation of Lifestyle Interventions for Preventing Diabetes and Cardiovascular Diseases

  2010cited by this paper
• Nutritional recommendations for preventing coronary heart disease in women: evidence concerning whole foods and supplements.

  2010cited by this paper
• The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia; a systematic review.

  2010cited by this paper
• Curcumin inhibits cholesterol uptake in Caco-2 cells by down-regulation of NPC1L1 expression

  2010cited by this paper
• Treating mixed hyperlipidemia and the atherogenic lipid phenotype for prevention of cardiovascular events.

  2010cited by this paper
• Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study.

  2010cited by this paper
• Plant stanols dose-dependently decrease LDL-cholesterol concentrations, but not cholesterol-standardized fat-soluble antioxidant concentrations, at intakes up to 9 g/d.

  2010cited by this paper
• Traditional uses and potential health benefits of Amorphophallus konjac K. Koch ex N.E.Br.

  2010cited by this paper
• Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance.

  2010cited by this paper
• Garlic flavonoids and organosulfur compounds: impact on the hepatic pharmacokinetics of saquinavir and darunavir.

  2010cited by this paper
• Nutritional supplements and serum lipids: Does anything work?

  2009cited by this paper
• Acute hepatitis caused by a natural lipid-lowering product: when "alternative" medicine is no "alternative" at all.

  2009cited by this paper
• Efficacy and safety of Monascus purpureus Went rice in children and young adults with secondary hyperlipidemia: a preliminary report.

  2009cited by this paper
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• The treatment of hypercholesterolemic children: efficacy and safety of a combination of red yeast rice extract and policosanols.

  2009cited by this paper
• Time- and dose-dependent effect of psyllium on serum lipids in mild-to-moderate hypercholesterolemia: a meta-analysis of controlled clinical trials

  2009cited by this paper
• Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

  2009cited by this paper
• The gut microbiota ecology: a new opportunity for the treatment of metabolic diseases?

  2009cited by this paper
• Berberine: metabolic and cardiovascular effects in preclinical and clinical trials

  2009cited by this paper
• Curcumin suppresses expression of low‐density lipoprotein (LDL) receptor, leading to the inhibition of LDL‐induced activation of hepatic stellate cells

  2009cited by this paper
• Gender-specific haemodynamic and metabolic effects of a sequential training programme on overweight-obese hypertensives

  2009cited by this paper
• The Effect of Adding Plant Sterols or Stanols to Statin Therapy in Hypercholesterolemic Patients: Systematic Review and Meta-Analysis

  2009cited by this paper
• Effect of 3-month treatment of children and adolescents with familial and polygenic hypercholesterolaemia with a soya-substituted diet

  2008cited by this paper
• The structure and function of Niemann–Pick C1-like 1 protein

  2008cited by this paper
• Biologically active components and nutraceuticals in the Monascus-fermented rice: a review

  2008cited by this paper
• Systematic review, meta-analysis and regression of randomised controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol.

  2008cited by this paper
• Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis.

  2008cited by this paper
• Efficacy of berberine in patients with type 2 diabetes mellitus.

  2008cited by this paper
• Vascular effects of diet supplementation with plant sterols.

  2008cited by this paper
• Natural sources of antidyslipidaemic agents: is there an evidence-based approach for their prescription?

  2008cited by this paper
• Efficacy and safety of Monascus purpureus Went rice in subjects with secondary hyperlipidemia

  2008cited by this paper
• Controversial role of plant sterol esters in the management of hypercholesterolaemia

  2008cited by this paper
• A combination of psyllium and plant sterols alters lipoprotein metabolism in hypercholesterolemic subjects by modifying the intravascular processing of lipoproteins and increasing LDL uptake.

  2007cited by this paper
• Eulipidemic Effects of Berberine Administered Alone or in Combination with Other Natural Cholesterol-lowering Agents

  2007cited by this paper
• Antioxidant and anti-inflammatory properties of curcumin.

  2007cited by this paper
• Esophageal obstruction from a hygroscopic pharmacobezoar containing glucomannan

  2007cited by this paper
• Curcumin: the Indian solid gold.

  2007cited by this paper
• Therapeutic effects of guggul and its constituent guggulsterone: cardiovascular benefits.

  2007cited by this paper
• Expert opinion: omega-3 fatty acids and bleeding-cause for concern?

  2007cited by this paper
• Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes

  2006cited by this paper
• Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review

  2006cited by this paper
• Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials

  2006cited by this paper
• Policosanol Inhibits Cholesterol Synthesis in Hepatoma Cells by Activation of AMP-Kinase

  2006cited by this paper
• The effects of berberine on the pharmacokinetics of cyclosporin A in healthy volunteers.

  2006cited by this paper
• Aged garlic extract may be safe for patients on warfarin therapy.

  2006cited by this paper
• Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders.

  2006cited by this paper
• Toxicological evaluation of red mould rice.

  2006cited by this paper
• Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial.

  2006cited by this paper
• Phytosterols/Stanols Lower Cholesterol Concentrations in Familial Hypercholesterolemic Subjects: A Systematic Review with Meta-Analysis

  2006cited by this paper
• Glucomannan and obesity: a critical review.

  2005influential reference
• eview-3 Long-Chain Polyunsaturated Fatty Acids in ype 2 Diabetes : A Review

  2005cited by this paper
• Antihyperlipidaemic effect of a Monascus purpureus brand dietary supplement on a large sample of subjects at low risk for cardiovascular disease: a pilot study.

  2005cited by this paper
• Effect of dietary supplementation with glucomannan on plasma total cholesterol and low density lipoprotein cholesterol in hypercholesterolemic children.

  2005cited by this paper
• Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients.

  2005cited by this paper
• Hypertensive crisis associated with high dose soy isoflavone supplementation in a post-menopausal woman: a case report [ISRCTN98074661]

  2005cited by this paper
• A quantitative risk-benefit analysis of changes in population fish consumption.

  2005cited by this paper
• Therapeutic lifestyle changes and pharmaceutical care in the treatment of dyslipidemias in adults.

  2005cited by this paper
• Guggul for hyperlipidemia: a review by the Natural Standard Research Collaboration.

  2005cited by this paper
• Effect of combining psyllium fiber with simvastatin in lowering cholesterol.

  2005cited by this paper
• Policosanol has no antioxidant activity in human low-density lipoprotein but increases excretion of bile acids in hamsters.

  2005cited by this paper
• Activation of the aryl hydrocarbon receptor by berberine in HepG2 and H4IIE cells: Biphasic effect on CYP1A1.

  2005cited by this paper
• n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review.

  2005cited by this paper
• Stanol esters as a component of maximal dietary therapy in the National Cholesterol Education Program Adult Treatment Panel III report.

  2005cited by this paper
• Acute hepatitis of cholestatic type possibly associated with the use of glucomannan (amorphophalus konjac).

  2004cited by this paper
• Soy Isoflavones Affect Sterol Regulatory Element Binding Proteins (SREBPs) and SREBP-Regulated Genes in HepG2 Cells 1,2

  2004cited by this paper
• Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

  2004cited by this paper
• Comparison of the Efficacy and Tolerability of Policosanol with Atorvastatin in Elderly Patients with Type II Hypercholesterolaemia

  2003cited by this paper
• Sex and hormonal status modulate the effects of psyllium on plasma lipids and monocyte gene expression in humans.

  2003cited by this paper
• Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial.

  2003cited by this paper
• Drug Interaction Potential of Soy Extract and Panax Ginseng

  2003cited by this paper
• Omega-3 Fatty Acids and Cardiovascular Disease: New Recommendations From the American Heart Association

  2003cited by this paper
• American Association of Clinical Endocrinologists medical guidelines for the clinical use of dietary supplements and nutraceuticals.

  2003cited by this paper
• A pilot study of the safety and efficacy of cholestin in treating HIV-related dyslipidemia.

  2002cited by this paper
• Glucomannan minimizes the postprandial insulin surge: a potential adjuvant for hepatothermic therapy.

  2002cited by this paper
• Effect of Soy Milk on Warfarin Efficacy

  2002cited by this paper
• Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent.

  2002cited by this paper

• Fluorescence sensing of berberine hydrochloride vians-Q[10]-based supramolecular assembly

  2025cites this paper
• The Lipid-Lowering Efficacy of a Nutraceutical Combination Including Leucoselect Phytosome, Red Yeast Rice, Policosanol and Folic Acid in Dyslipidaemia Patients: Real-World Insights

  2024cites this paper
• Cyanuric chloride-modified dendritic SiO2 nanoparticle for switch-on fluorescence monitoring and dispersive solid-phase extraction of isoquinoline alkaloids.

  2024cites this paper
• The effects of policosanol supplementation on blood glucose: A systematic review and dose-response meta-analysis of randomized controlled trials.

  2024cites this paper
• Efficacy of Food Supplement Based on Monacolins, γ-Oryzanol, and γ-Aminobutyric Acid in Mild Dyslipidemia: A Randomized, Double-Blind, Parallel-Armed, Placebo-Controlled Clinical Trial

  2024cites this paper
• Pattern Recognition of Alkaloids by Inhibiting the Catalytic Activity of Dopzymes for Dopamine.

  2024cites this paper
• Pyrene-Functionalized Graphene Oxide for Fluorescent Detection of Berberine

  2024cites this paper
• Covalent organic framework enhanced aggregation-induced emission of berberine and the application for detection

  2023cites this paper
• Herbal therapies for weight gain and metabolic abnormalities induced by atypical antipsychotics: a review article.

  2023cites this paper
• Fluorescence "light-up" sensor based on ligand/SiO2@NH2@cyanuric chloride nanoparticle interactions in alliance with salt dehydration for berberine detection.

  2023cites this paper
• Effectiveness in the short-term of a novel nutraceutical for the management of hypercholesterolemia: an observational multicenter primary care experience

  2022cites this paper
• Protective effects of berberine on various kidney diseases: Emphasis on the promising effects and the underlined molecular mechanisms.

  2022cites this paper
• Clinical Analysis of the Renal Protective Effect of GLP-1 on Diabetic Patients Based on Edge Detection

  2022cites this paper
• Nutraceuticals in Paediatric Patients with Dyslipidaemia

  2022cites this paper
• A Review of the Effects of Policosanol on Metabolic Syndrome

  2022cites this paper
• Omics as a Tool to Help Determine the Effectiveness of Supplements

  2022cites this paper
• Plasma polyunsaturated fatty acid concentrations and sleep apnea risk: A two-sample Mendelian randomization study

  2022cites this paper
• Uncovering Prospective Role and Applications of Existing and New Nutraceuticals from Bacterial, Fungal, Algal and Cyanobacterial, and Plant Sources

  2021cites this paper
• Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?

  2021cites this paper
• Benzothiazole derivative-functionalized carbon dots for the detection of berberine hydrochloride

  2021cites this paper
• Nutraceuticals: Scientific and Legal Definitions around the World

  2021cites this paper
• Are Nutraceuticals Beneficial in Chronic Kidney Disease?

  2021cites this paper
• A Sensitive and Selective Fluorescent Sensor for Berberine Chloride Based on the Supramolecular Self-Assembly of Perylene Diimide in Aqueous Solution

  2020cites this paper
• A Fluorometric and Colorimetric Approach for the Rapid Detection of Berberine Hydrochloride Based on an Anionic Polythiophene Derivative.

  2020cites this paper
• Epigallocatechin-3-Gallate Toxicity in Children: A Potential and Current Toxicological Event in the Differential Diagnosis With Virus-Triggered Fulminant Hepatic Failure

  2020cites this paper
• Drug interactions related to self‐medication: a French pharmacovigilance database study

  2020cites this paper
• Lipid-lowering nutraceuticals update on scientific evidence

  2020cites this paper
• Host-guest co-assembly triggered turn-on and ratiometric sensing of berberine and its detoxicating

  2020cites this paper
• A double-blind, placebo-controlled clinical trial to assess the effects of a combined nutraceutical on endothelial function in patients with mild-to-moderate hypercholesterolaemia

  2020cites this paper
• Effects of Nutritional Supplements on Human Health

  2019cites this paper
• A CLINICAL STUDY TO EVALUATE THE EFFICACY OF A NEW NEUTRACEUTICAL COMBINATION BASED ON RESVERATROL, BERBERISAND ASTRALAGUS EXTRACTS IN COMPARISIONTO A FORMULATION CONTAININGRED YEAST RICE (MONACOLIN K) IN PATIENTS WITH MODERATE DYSLIPIDEMIA

  2019influential citation
• Rapid and visual detection of berberine hydrochloride based on a water-soluble pyrene derivative.

  2019cites this paper
• Pharmacological effects of berberine on mood disorders

  2018cites this paper
• Ameliorating Effects of Four-Week Fiber-Multivitamin Combination Treatment on Low-Density Lipoprotein Cholesterol, Total Cholesterol, and Apolipoprotein B Profiles in Hypercholesterolemic Participants

  2018cites this paper
• Lipid-lowering activity of artichoke extracts: A systematic review and meta-analysis

  2018cites this paper
• Riso rosso fermentato, monacolina K ed effetti pleiotropici

  2018cites this paper
• Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

  2017cites this paper
• Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

  2017cites this paper
• Bioimpedance analysis, metabolic effects and safety of the association Berberis aristata/Bilybum marianum: a 52-week double-blind, placebo-controlled study in obese patients with type 2 diabetes.

  2017cites this paper
• Viral Upper Respiratory Infection

  2017cites this paper
• Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease Risk: A Double-Blind, Placebo-Controlled Randomized Clinical Trial

  2017cites this paper
• Efficacy and tolerability of a combined lipid-lowering nutraceutical on cholesterolemia, hs-CRP level and endothelial function in moderately hypercholesterolemic subjects.

  2016cites this paper
• Anti‐infective potential of Citrus bergamia Risso et Poiteau (bergamot) derivatives: a systematic review

  2016cites this paper
• Konjac glucomannan, a promising polysaccharide of Amorphophallus konjac K. Koch in health care.

  2016cites this paper
• Additional therapy for cholesterol lowering in ezetimibe-treated, statin-intolerant patients in clinical practice: results from an internal audit of a university lipid clinic

  2016cites this paper
• Middle-Term Dietary Supplementation with Red Yeast Rice Plus Coenzyme Q10 Improves Lipid Pattern, Endothelial Reactivity and Arterial Stiffness in Moderately Hypercholesterolemic Subjects

  2016cites this paper
• A placebo-controlled trial of a proprietary lipid-lowering nutraceutical supplement in the management of dyslipidemia.

  2016cites this paper
• Lipid-modifying effects of nutraceuticals: An evidence-based approach.

  2016cites this paper
• Effect of red yeast rice combined with antioxidants on lipid pattern, hs-CRP level, and endothelial function in moderately hypercholesterolemic subjects

  2016cites this paper
• Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: The available clinical data.

  2016cites this paper
• Effects of a Combined Nutraceutical on Lipid Pattern, Glucose Metabolism and Inflammatory Parameters in Moderately Hypercholesterolemic Subjects: A Double-blind, Cross-over, Randomized Clinical Trial

  2016cites this paper
• Role of phytochemicals in the management of metabolic syndrome.

  2016cites this paper
• effect of red yeast rice combined with antioxidants on lipid pattern, hs-CRP level, and endothelial function in moderately hypercholesterolemic subjects

  2016cites this paper
• Nutraceuticals and cholesterol-lowering action

  2015cites this paper
• Possible therapies for obesity: focus on the available options for its treatment.

  2015cites this paper
• Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study

  2015cites this paper
• Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease.

  2015cites this paper
• Potential Benefits of Berberine in the Management of Perimenopausal Syndrome

  2015cites this paper
• Berberis aristata/Silybum marianum fixed combination (Berberol(®)) effects on lipid profile in dyslipidemic patients intolerant to statins at high dosages: a randomized, placebo-controlled, clinical trial.

  2015cites this paper
• Subjective effects of a combined lipid-lowering nutraceutical or ezetimibe on well-being and sexual performance in patients with perceived worsening of erectile function during statin treatment: a randomised clinical trial

  2015cites this paper
• Statins and Nutraceuticals/Functional Food: Could They Be Combined?

  2015cites this paper
• Ameliorative Effects of Nutraceuticals in Neurological Disorders

  2015cites this paper
• Nutraceuticals for Serum Lipid and Blood Pressure Control in Hypertensive and Hypercholesterolemic Subjects at Low Cardiovascular Risk

  2015cites this paper
• Factors associated with 2-year persistence in fully non reimbursed lipid-lowering treatments.

  2014cites this paper
• A randomized, placebo-controlled study on the effects of a nutraceutical combination of red yeast rice, silybum marianum and octasonol on lipid profile, endothelial and inflammatory parameters.

  2014cites this paper
• Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects.

  2013cites this paper
• Berberis aristata/Silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients

  2013cites this paper
• Effect of a Lipid-Lowering Nutraceutical on Pulse-Wave-Velocity in Hypercholesterolemic Patients with or without Chronic Kidney Disease

  2013cites this paper
• Reduction of cholesterol and other cardiovascular disease risk factors by alternative therapies

  2013cites this paper
• Nutraceuticals with lipid-lowering activity: do they have any effect beyond cholesterol reduction?

  2012cites this paper